Research shows there is a strong link between dietary patterns and age-related macular degeneration (AMD).
People with diets that are elevated in fat, cholesterol, and high glycemic index foods, and low in antioxidants and green leafy vegetables may be more likely to develop AMD. High-glycemic index foods, such as white rice, bread, and pasta raise blood sugar rapidly, whereas low-glycemic foods, such as whole-grain bread or oatmeal may lower the risk of AMD.
Currently, AREDS2 eye vitamins are the standard treatment aimed at preventing intermediate-stage age-related macular degeneration (AMD) from worsening to advanced AMD (dry or wet).
AREDS2 is short for Age-Related Eye Disease Study 2, the sequel clinical trial conducted by The National Eye Institute (NEI), within the U.S. National Institutes of Health (NIH)
The formula for these AREDS2 eye vitamins combine specific dosages of vitamins C and E, the carotenoids lutein and zeaxanthin, and the minerals zinc, and copper. When used in intermediate-stage AMD, AREDS2 vitamins reduce the risk of developing vision-threatening, advanced AMD, and are recommended by many doctors.
Research is showing there may be additional ways to lower risk, given how sensitive the eye is to nutritional intake and possible deficiencies.
Explore More of Our 360° Research Approach
- Retinal Pigment Epithelium
- Geographic Atrophy
- Cell Metabolism
- Immune Response
- Regenerating Cells
- Innovative Treatment Approaches
Retinal Pigment Epithelium
It is generally thought that age-related macular degeneration (AMD) begins in the retinal pigment epithelium (RPE), a single layer of cells next to the retina, whose job is to transport molecules in and out to nourish the retina and dispose of waste. The RPE’s ability to do its job can be compromised by age, oxidative stress, inflammation, and other factors causing the immune system to kick in and overact.
Some patients with age-related macular degeneration (AMD) will develop geographic atrophy (GA), which refers to patches or regions of the retina where cells waste away and die (atrophy). Sometimes these regions of atrophy look like a map to the doctor who is examining the retina, hence the term geographic atrophy.
The retinal pigment epithelium (RPE) is a single layer of cells at the back of the eye next to the retina. The health of RPE cells, and their ability to support the nerve cells of the retina, depend on well-functioning RPE cell metabolism as a source of energy.
The immune system is designed to fight off infections. To do this, it must be able to tell the difference between our own cells (and leave them alone) versus invading bacteria or viruses (and attack them). As we age, our cells are altered by “oxidative” damage and accumulation of debris (i.e environmental toxins like sun, chemicals, tobacco smoke, and other pollution) , which can cause the immune system to attack its own cells.
Age-related macular degeneration (AMD) is caused by a number of genetic and environmental factors.
Genes may be one way to lower the risk of AMD, if researchers can block or replace signals from genes that trigger disease, and promote the survival and integrity of the retinal pigment epithelium (RPE) cells when they encounter oxidative stress from aging and other causes.
Unlike skin and other parts of the human body, the nerve cells of the eyes do not, for the most part, regrow or regenerate after damage has occurred. However, there is new hope. Work is moving forward to regenerate and reconnect the eye’s retinal cells that have been damaged by age-related macular degeneration (AMD), and to restore the underlying retinal pigment epithelium (RPE) cells that provides its nourishment and support.
Innovative Treatment Approaches
One day, we may be able to detect signs that age-related macular degeneration (AMD) is developing and take early steps to defend against it. Macular Degeneration Research is funding research into unique ways to protect the retinal pigment epithelium (RPE) and retina at earlier stages, before damage to sight has occurred.